Utilizing the Tumor-Node-Metastasis Staging for Prostate Cancer: The Sixth Edition, 2002 -- Chang and Amin 58 (1): 54 -- CA: A Cancer Journal for Clinicians

[Guest guest]

http://caonline.amcancersoc.org/cgi/content/short/58/1/54

CA Cancer J Clin 2008; 58:54-59

doi: 10.3322/CA.2007.0002

Utilizing the Tumor-Node-Metastasis Staging for Prostate Cancer

The Sixth Edition, 2002

Sam S. Chang, MD and Mahul B. Amin, MD

Dr. Chang is Associate Professor of Urologic Surgery, Vanderbilt University

Medical Center, Nashville, TN.

Dr. Amin is Chairman, Department of Pathology & Laboratory Medicine,

Cedars-Sinai Medical Center, Los Angeles, CA.

Published online through CA First Look at http://CAonline.AmCancerSoc.org.

To earn free CME credit for successfully completing the online quiz based on

this article, go to http://CME.AmCancerSoc.org.

The Sixth Edition of the tumor-node-metastasis staging system for prostate

cancer attempts to provide a helpful staging paradigm for clinicians.

Accurate staging is critical not only for managing individual patients, but

also for ascertaining trends in disease pattern in a large population of

patients with prostate cancer. Several modifications have been made in an

attempt to improve the cohesiveness and uniformity of patient evaluation and

to aid in future meaningful clinical research. As data are accumulated and

analysis continues, ongoing critical evaluation of this staging system will

undoubtedly incorporate new evidence-based factors and bring about future

refinements to prostate cancer staging.